Skip to main content
. Author manuscript; available in PMC: 2011 Nov 28.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Jul;54(3):317–323. doi: 10.1097/QAI.0b013e3181ced126

Table 3.

HIV testing results of clients attending three mobile HCT approaches compared to stand–alone HCT

Stand-Alone HCT All Mobile HCT Community-Site Mobile HCT Semi-Mobile Container HCT Fully-Mobile Truck HCT
HIV Prevalence in Client Groups (% of total, [95% Confidence Interval] (# people tested positive/N))
All Clients* 14.1% [13.5–14.7] (2065/14634) 9.0% [8.7–9.2] (4265/47539) 8.2% [7.9–8.6] (1699/20599) 5.4% [5.0–5.7] (927/17227) 16.9% [16.1–17.6] (1639/9713)
Female 21.2% [20.1–22.2] (1256/5931) 12.7% [12.3–13.2] (2564/20128) 12.0% [11.4–12.7] (1137/9457) 5.1% [4.7–5.5] (541/10671) 21.7% [20.5–23.0] (886/4076)
Male1 9.3% [8.7–9.9] (809/8703) 6.2% [5.9–6.2] (1701/27411) 5.0% [4.6–5.5] (562/11142) 5.9% [5.3–6.5] (386/6556) 13.4% [12.5–14.3] (753/5637)
Age 15–24 yrs 7.7% [7.1–8.4] (477/6158) 4.8% [4.6–5.1] (1071/22084) 3.6% [3.3–4.1] (324/8882) 3.4% [3.0–3.7] (296/8824) 10.3% [9.4–11.2] (451/4378)
New testers 19.2% [18.3–20.0] (1612/8415) 9.0% [8.8–9.3] (3782/41829) 8.3% [7.9–8.7] (1554/18682) 5.4% [5.0–5.8] (792/14682) 16.9% [16.2–17.8] (1436/8465)
HIV Discordant (in Couples) 11.6% [10.4–12.8] (304/2616) 4.4% [3.1–5.8] (40/902) 4.8% [2.2–7.4] (12/250) 2.8% [2.0–3.7] (40/1412) 19.7% [13.2–26.2] (28/142)
*

Includes only clients completing all components of HCT.

Missing data for variables assessed were too small to report.

1

Male is defined as non-entry in female field. May include some cases where data were missing.